1379922-51-6

Basic information

• Product Name: RCS-4 3-methoxy isomer
• Synonyms: RCS-4 3-methoxy isomer;(3-methoxyphenyl)-(1-pentylindol-3-yl)methanone
• CAS NO: 1379922-51-6
• Molecular Formula: C21H23NO2
• Molecular Weight: 321.41282
• Mol File: 1379922-51-6.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: RCS-4 3-methoxy isomer(CAS DataBase Reference)
• NIST Chemistry Reference: RCS-4 3-methoxy isomer(1379922-51-6)
• EPA Substance Registry System: RCS-4 3-methoxy isomer(1379922-51-6)

Safety Data

• Hazardous Substances Data: 1379922-51-6(Hazardous Substances Data)

Usage

Description

RCS-4 3-methoxy isomer is an RCS-4 analog, designed based on the structure of the synthetic cannabinoid JWH 018. It exhibits high binding affinity to both central (CB1) and peripheral (CB2) cannabinoid receptors, with Kis values of 9.0 and 2.94 nM, respectively. However, its biological activity has not been reported yet.

Uses

Used in Pharmaceutical Industry:
RCS-4 3-methoxy isomer is used as a potential therapeutic agent for various conditions due to its high binding affinity to CB1 and CB2 cannabinoid receptors. The application reason is that these receptors are involved in regulating several physiological processes, including pain, inflammation, and mood, which makes RCS-4 3-methoxy isomer a promising candidate for the development of new drugs targeting these receptors.
Used in Research and Development:
RCS-4 3-methoxy isomer is used as a research tool for studying the structure-activity relationship of cannabinoids and their interactions with CB1 and CB2 receptors. The application reason is that understanding these interactions can help in the design and development of more effective and selective cannabinoid-based drugs.
Used in Drug Delivery Systems:
RCS-4 3-methoxy isomer can be used as a component in the development of novel drug delivery systems, aiming to improve its bioavailability, delivery, and therapeutic outcomes. The application reason is that its high binding affinity to cannabinoid receptors can potentially enhance the efficacy of the drug delivery system, making it more effective in treating various conditions.